GlaxoSmithKline has asked a Massachusettes Federal Court on Monday, to strike the fraud-based claim regarding the marketing of the anti-nausea drug named Zofran. At present, it has a multidistrict litigation that alleges that the drug Zofran is linked to a variety of birth defects. They go on to state that it will be prejudiced should […]

Read More →